Promoter collection, Human GADD45B promoter
Alternative name | U2845-7 |
---|---|
Clone info. | PCR amplified human GADD45B promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 2474664 to 2476169(NC_000019.10); relatively -1463 to +43, where +1 corresponds to 1 nt of NM_015675.4. |
Comment | PCR cloning, forward primer: CCCGTCCGTCCCTCTCTTC; reverse primer: GGAAGTTGCGGAAACCAACG. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human DKFZp566B133, GADD45BETA, MYD118 genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07529.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07529 | pGL4-phGADD45B | DNA solution |
Materials & Methods section:
The pGL4-phGADD45B was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07529). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07529_A5Bn.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07529_A5Bna.seq |
---|
>07529_07529_A5Bn_pGL4-4174F_F03_18.ab1 1 AGCAGGGTCA GACATTTCTC TGGCCTAACT GGCCGGTACC TGAGCTCGCT AGCCTCGAGG 61 ATCCCGTCCG TCCCTCTCTT CCGGCGCTGA GGGCGCAGAA ACTCGGCGCG GCCACCAGAT 121 GGCGCCACCG CGCCTCGCAG CCCCGGGACA TTTCGTGCCC CAGCGGTGGG CGGCGCGGAG 181 GAGGTGGGAT GCGTCAGCCG GACCCGCGGG CCGGGGAGCC GGGCAACTGG GGAAAGTGAG 241 CCGCCGGGCG GAGGCCAGAC CCCAGGCTGG CGGGGGAGGG GACTCAGATG TGAGTCACCC 301 GGGAGCCCCC AGTCGACCGT GGGAGACGTT GTCATGCGGG GCCTGCCAGC CTCGCTCCTG 361 AACAGCCTTC CCGGGGCGGC GGAGTCCTGC AGGCGGCCGT GCCTGGCGCA CACGCGTGGC 421 TCCAACACGA ACTAGCCTAT GGCCTCACCA AGCCTCAGTT TCCCCTTTTG CATAATGCAC 481 ATAAGCATCC CCCCTGCTTC CCAGGTCTTG GATTAAATCA TCCATGAATC CGGAGGGGTG 541 GGGGGTACCA GGTCCGCACC ACGCACTCAA TGCAGGTCAG CGCCCACCCC GGAGTGAGAA 601 ATAAAAGTAG CCGTCATCCT TGCACGTGGG CCCTGGGTGG CGGCGTGCAG CCGGAGCCTG 661 CACCATTCCC CTCAACAATG GCTTTCTCCC GGGCCTGGAG GCCTCCGCAC GGGCAAAGGC 721 TGGAACGCCA GGCAGCCGGC GGGGGCGGGG CCGCGCCACC TGCACCTCCC ACGCGCACCC 781 CACCCTGATA CTCGCGGGGT CGGCGAGGAG GCGCCCACTT TCTTCTCCAG AGCGCCCCGG 841 GCTTTGCAAC CTCCCACTTT CGGGGCCCTC GAGGAGGCCT CCCGCGACCA CCAGGTGACA 901 GCTGATGTGT ATTGGGCTCT TACTGTCAGC CGTATTTTAT GCCATGCTCT GCAAACCAGC 961 GAGGCCGGCG CTGCAGACCC ATTACTCAGA CGGGAACAGA GAGGCCCGGG AGAAGCGAAA 1021 TCACCCAGGG GCTGGGGGTC GTCGCAGCCA GGAGAGACTC CGGCCCTCAC CACCAACTGG 1081 GCGAGATCAC GCTGCAAACG GGATCCGATC CCGATGCAGC CCCTTCCAAC CCCAAGCCAG 1141 AACTTGGGTA AAGGCGCGCG CGG // |
Primer: pGL4-136R Sequence file: RDB07529_A5Bnb.seq |
>07529_07529_A5Bn_pGL4-136R_G03_21.ab1 1 GTCTTTTGCT TTTGGCATCT TCCATGGTGG CTTTACCAAC AGTACCGGAT TGCCAAGCTT 61 GGCCGCCGAG GCCAGATCTT GATGGAAGTT GCGGAAACCA ACGGTAGTCC GACGCTTCGG 121 CGATCTGAGC TGGGAGCCTC CGGCACCGAC TTTTATAGAC TTGAACATTG GGCGTGGCCT 181 CAGTGGAGTC ATTCGCCCCT CCTATTGGTG GAAAGACAAG GGCGAGTGCA GCTAGCTCTG 241 CGGTTGGCCG ACGGAGGGGA GGGGGAGGAG CGGCGTGCGG GGGCGCCCCA CGTGGGGGCG 301 AGAACCGGGA GGAGGGCGCG CGGGGGCCGG GTAGGTGACC GCGAATGCCA GAAAAGAAAA 361 AAAAGCAGAA GTTTTTTTCT CCTGATTTCC CGGCAGCCGA GCCGCGGTTC GGGGCGCGCG 421 CGGGATTTCC AGCGCGCGAG GCGGCCCGGA CTTTCGGGGG GGCCTGGAAT CCCCTCCCGA 481 TCCGCGGAGA GTCCCGGACC GCGCCTTTCC CAAGTTCTGC TGGGGGTGGA GGGGCTGCAC 541 CGGGAAGGGG CCCCGTTTGC AGCGTGATCT CGCCCAGGTG GTGGTGAGGG CCGGAGTCTC 601 TCCTGGCTGC GACGACCCCA GCCCCTGGGT GATTTCGCTT CTCCCGGCCT CTCTGTTCCC 661 GTCTGAGTAA TGGGTCTGCA GCGCCGGCCT CGCTGGTTTG CAGAGCATGG CATAAAATAC 721 GGCTGACAGT AAGAGCCCAA TACACATCAG CTGTCACCTG GTGGTCGCGG GAGGCCTCCT 781 CGAGGGCCCC GAAAGTGGGA GGTTGCAAAG CCCGGGGCGC TCTGGAGAAG AAAGTGGGCG 841 CCTCCTCGCC GACCCCGCGA GTATCACGGG TGGGGTGCGC GTGGGAGGTG CAGGTGGCGC 901 GGCCCCGCCC CCGCCGGCTG CCTGGCGTTC CAGCCTTTGC CCGTGCGGAG GCCTCCAGGC 961 CCGGGAGAAG CCATTGTTGA GGGGAATGTG CAGCTCCGGC TGCACGCCGC CACCCAGGCC 1021 CACGTGCAGG ATGACGGCTA CTTTTATTTC TCACTCCGGG GTGGCGCTGA ACTTGCAATT 1081 GATTGCCTTG TGCCGAACTG GTACCCTCAT CCTTCCGGAA TCCATGATGA ATTAATTCCA 1141 AGACCTTGGG // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content